ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.
People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the left atrial appendage (LAA).